Anebulo Pharmaceuticals (ANEB) Common Equity (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Common Equity of $7.94 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 47.0% from $14.96 million a year earlier and down 18.5% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Common Equity (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals posted Common Equity of $11.66 million, up 205.8% from FY2024.
- By fiscal year, Common Equity came in at $3.81 million in FY2024 (-64.0%), $10.6 million in FY2023 (-29.6%), $15.07 million in FY2022 (-29.6%) and $21.41 million in FY2021.
- The fiscal Q2 2026 figure ranks as the lowest quarterly Common Equity since fiscal Q1 2025.
- Year over year, Common Equity gained in four of the last eight quarters, with growth averaging 83.7%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2026 (growth of 412.8%); the low point was fiscal Q1 2025 (a decline of 77.2%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $9.74 million (Q1 2026), $11.66 million (Q4 2025) and $13.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 7.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.94 Mn |
| Sep 30, 2025 | 9.74 Mn |
| Jun 30, 2025 | 11.66 Mn |
| Mar 31, 2025 | 13.46 Mn |
| Dec 31, 2024 | 14.96 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 10.60 Mn |
| Mar 31, 2023 | 12.94 Mn |
| Dec 31, 2022 | 15.52 Mn |
| Sep 30, 2022 | 19.12 Mn |
| Jun 30, 2022 | 15.07 Mn |
| Mar 31, 2022 | 17.16 Mn |
| Dec 31, 2021 | 18.91 Mn |
| Sep 30, 2021 | 19.89 Mn |
| Jun 30, 2021 | 21.41 Mn |
| Mar 31, 2021 | -9.44 Mn |
API Access
Anebulo Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();